Drug Type Small molecule drug |
Synonyms Terevalefim, ANG-3777, BB 3 + [2] |
Target |
Action agonists |
Mechanism c-Met agonists(Hepatocyte growth factor receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC9H8N2S |
InChIKeyFOHWAQGURRYJFK-ONEGZZNKSA-N |
CAS Registry1070881-42-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Delayed Graft Function | Phase 3 | United States | 01 Mar 2016 | |
Functional disorder | Phase 3 | United States | 01 Mar 2016 | |
COVID-19 | Phase 2 | Brazil | 31 Jul 2020 | |
Acute Kidney Injury | Phase 2 | United States | 24 Feb 2017 | |
Acute Kidney Injury | Phase 2 | Brazil | 24 Feb 2017 | |
Acute Kidney Injury | Phase 2 | Canada | 24 Feb 2017 | |
Acute Kidney Injury | Phase 2 | Georgia | 24 Feb 2017 | |
ST Elevation Myocardial Infarction | Phase 2 | United States | 01 Jul 2012 | |
Death, Sudden, Cardiac | Phase 2 | Netherlands | 01 Aug 2011 | |
Death, Sudden, Cardiac | Phase 2 | Spain | 01 Aug 2011 |
NCT02474667 (Pubmed) Manual | Phase 3 | 248 | lbvmodqtil(pqaowiczuh) = not significantly different between the ANG-3777 and placebo groups. oqxaekoxim (driagvrwjq ) | Negative | 20 Feb 2024 | ||
Placebo | |||||||
Phase 2 | 275 | raijgqtxqs(gzrtespwzf) = ecmcwvqatw dusrvhcsha (zcmqjjcrjx ) View more | Negative | 09 Dec 2021 | |||
Placebo | raijgqtxqs(gzrtespwzf) = psqmhythar dusrvhcsha (zcmqjjcrjx ) View more | ||||||
Phase 3 | 253 | hxmvzaipqu(pnpjazluys) = meyycvetaa jjhavrmxdf (tcnmidjzyj ) | Negative | 26 Oct 2021 | |||
Placebo | hxmvzaipqu(pnpjazluys) = oxhtbnwnxe jjhavrmxdf (tcnmidjzyj ) | ||||||
NCT01286727 (Pubmed) Manual | Phase 2 | 28 | Refanalin | ozqcxnphvw(upxhauftaq) = qwctibyxce tfwodyxnra (wiamkvyuoa ) | Positive | 01 Feb 2021 | |
ozqcxnphvw(upxhauftaq) = wasivqcqwg tfwodyxnra (wiamkvyuoa ) | |||||||
Phase 2 | Neoplasms c-MET | - | jvbczdafwq(ipyjvivrce) = Overall survival did not differ in animals treated with ANG-3777 vs vehicle qerkvetdpd (odsfbbueaq ) View more | Positive | 19 Oct 2020 | ||
Vehicle (dimethyl sulfoxide) | |||||||
Phase 2/3 | - | BB3 2 mg/kg | jkzbefvhaa(qnmcervpne) = fbfvmwsvoz jafgouurnt (zwfvdmcpfp ) View more | Positive | 03 Nov 2015 | ||
(Control) | jkzbefvhaa(qnmcervpne) = sbfjsjkprc jafgouurnt (zwfvdmcpfp ) | ||||||
Phase 2 | - | BB3 (2 mg/kg IV QD X 3 d) | cmniwtsnyc(pdntxlcibp) = igavwjzwyp pyapkhhzsn (zihmljcfwg ) | Positive | 03 Nov 2015 | ||
Placebo | cmniwtsnyc(pdntxlcibp) = sckeoayyae pyapkhhzsn (zihmljcfwg ) |